Fibromyalgia Trial, Recruiting NCT06579261 Sponsor: University of California, Irvine Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT06579261
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are female
  • You are between 18 and 75 years old
  • You have been diagnosed with fibromyalgia and meet the 2016 official diagnostic criteria for fibromyalgia
  • Your average pain level over the past 7 days has been 4 or higher on a 10-point scale
  • You are willing to avoid starting new medications or treatments for your fibromyalgia while in the study
  • You are able to travel to the study location for treatment sessions up to twice a week
  • You are willing and able to follow all study procedures from start to finish
  • You are able to sign a written consent form agreeing to take part
  • You can speak, read, and write in English well enough to participate

Who may not be able to join:

  • You have another condition that causes pain and involves the immune system, such as rheumatoid arthritis, lupus, or inflammatory bowel disease
  • You have a history of a serious head injury where you lost consciousness
  • You have nerve damage in your hands or feet (from a known cause) that interferes with everyday activities
  • You regularly take opioid pain medicines, use marijuana daily, or have a history of substance abuse
  • You take stimulant medications, such as those used for ADHD (for example, Adderall or Ritalin) or for staying awake (for example, modafinil)
  • You are currently taking part in another medical treatment trial
  • You take over-the-counter pain relievers like ibuprofen as needed on the day of a brain activity (EEG) test
  • You have taken opioid pain medicines within 48 hours before a brain activity (EEG) test
  • You are currently pregnant or breastfeeding (a pregnancy test will be done before brain activity testing sessions)
  • You have a serious mental health condition such as schizophrenia, severe depression with thoughts of suicide, or a history of substance abuse within the past two years
  • You have metal implants, surgical clips, staples, or certain metal dental materials that would make brain activity (EEG) testing unsafe (confirm with trial site)
  • You have any condition or situation that the study team feels would prevent you from completing the study safely and reliably
  • You already have significant knowledge of shamanism techniques, which could affect the study results
  • You have any factors that would make it unsafe for you to receive the shamanism-based treatment used in this study (confirm with trial site)
  • You have had vascular (blood vessel) surgery in your legs, or you currently have blood vessel problems in your legs
  • You have heart or cardiovascular disease that is not well controlled
  • You are involved in a workers' compensation claim, legal case, disability claim, or are receiving financial compensation related to your fibromyalgia
  • You are unwilling or unable to sign a written consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Richard E Richard, PhD, UCI SSIHI

Phone: 949-824-7000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of California, Irvine
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Primary Outcomes: Attendance Measurement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov